Janssen is working to develop new approaches in a bid to bolster patient-centricity in its trial process, according to a recent Clinical Leader report.
Janssen Clinical Innovation’s Tammy Guld tells Clinical Leader the key is to “get patients more involved throughout the entire study.”
“We need to ensure their insights and input are considered at the study design phase and throughout the clinical trial process,” she said. “Their insights need to be embedded into processes throughout the entire sponsor organization.”
To read the full report, click here.
